-
Analyst Opinions
Budget Hotels Market Trends and Analysis by Region, Deals and Competitive Landscape
Budget Hotels Market Report Overview The budget hotels market was valued at $95.92 billion in 2022. The decrease in COVID travel restrictions has led to a growing number of budget-conscious travelers, the rise of online booking platforms, and increasing travel and tourism, which became the major contributors to the growth of budget hotel revenue during 2022. Buy the Full Report for Additional Insights on the Budget Hotels Market Download a Free Report Sample The budget hotels market research report provides...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pixofisiran in Hypertrophic Scars
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pixofisiran in Hypertrophic Scars report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lixadesiran + Pixofisiran in Hypertrophic Scars Drug Details: STP705 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pixofisiran in Abdominal Obesity
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pixofisiran in Abdominal Obesity report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lixadesiran + Pixofisiran in Abdominal Obesity Drug Details: STP705 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Retifanlimab in Hypopharyngeal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Retifanlimab in Hypopharyngeal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Retifanlimab in Hypopharyngeal Cancer Drug Details: Retifanlimab (Zynyz) is a humanized...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – APNmAb-005 in Tauopathies
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - APNmAb-005 in Tauopathies report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.APNmAb-005 in TauopathiesDrug Details: APNmAb-005 is under development for the treatment of Alzheimer’s disease...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MV-140 in Urinary Tract Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MV-140 in Urinary Tract Infections report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MV-140 in Urinary Tract Infections Drug Details: MV-140 (Uromune) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CTX-712 in Relapsed Acute Myeloid Leukemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CTX-712 in Relapsed Acute Myeloid Leukemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CTX-712 in Relapsed Acute Myeloid Leukemia Drug Details: CTX-712 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Arsenic Trioxide in Myeloproliferative Disorders
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Arsenic Trioxide in Myeloproliferative Disorders report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Arsenic Trioxide in Myeloproliferative Disorders Drug Details:Arsenic trioxide is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – XT-150 in Neuropathic Pain (Neuralgia)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.XT-150 in Neuropathic Pain (Neuralgia) Drug Details:XT-150 is under development for the treatment of neuropathic pain,...